A THC-Positive Driver Case Series Did Not Supply a Drug-Free Specificity Group

A study selected from THC-positive driver investigations cannot establish drug-free specificity without a suitable negative comparison group. A two-year case review provides useful observations within its selected cases, but it does not answer every diagnostic-accuracy question.

Selection happened before the final analysis

Declues and colleagues began with THC-positive cases from suspected drug-driving investigations. They excluded cases for reasons including insufficient blood, other drugs or suspected untested substances, and incomplete or unsuitable records. The final analysis included 363 selected cases.

That process produced a narrower group for examining driving observations and field sobriety findings. It did not create a representative sample of all drivers or a control group of drivers without THC.

A positive case series cannot fill every cell

Specificity concerns how often a test is negative among people without the target condition. To estimate it, the study needs observations from that comparison group using an appropriate reference definition.

Finding field-test signs frequently in THC-positive cases does not establish how often the same signs occur without THC. Nor is THC positivity itself a direct reference for functional impairment. These distinctions remain necessary even when known additional drugs have been excluded.

Preserve the reported finding and its limits

The study reported no correlation between THC concentration and field-test performance in its selected sample. That finding cautions against a simple concentration-to-performance rule; it does not demonstrate that cannabis has no driving effects.

The article can inform discussion of observed THC-positive investigations. It cannot supply a drug-free false-positive rate from a group it did not include. A useful interpretation identifies both the selection process and the outcome before quoting sensitivity or specificity.

Related: How the reference specimen changes a cannabis accuracy claim.

Research cited

Declues K; Perez S; Figueroa A; Journal of Forensic Sciences; 2016. A 2-Year Study of Delta-9-tetrahydrocannabinol Concentrations in Drivers: Examining Driving and Field Sobriety Test Performance.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Oral THCA-A Exposure Did Not Produce Detectable Hair THCA-A in One Volunteer

In a small controlled experiment, one volunteer took oral THCA-A repeatedly without producing detectable THCA-A in the sampled hair or sebum/sweat. That finding questions a simple assumption that systemic exposure necessarily yields a positive hair result for the same cannabinoid. This experiment tested the plant acid Moosmann and colleagues reported…

Spread the love

Read Article: Oral THCA-A Exposure Did Not Produce Detectable Hair THCA-A in One Volunteer

CB2 Effects on Established Neuropathy Did Not Establish Prevention of Its Onset

An experimental CB2 agonist could reduce hypersensitivity after neuropathy was established while only delaying its development under another treatment schedule. A mouse study illustrates why treatment of an existing response and prevention of its onset need separate evidence. The experiments asked different timing questions The supplied Guenther and colleagues preprint…

Spread the love

Read Article: CB2 Effects on Established Neuropathy Did Not Establish Prevention of Its Onset

A CB1 Modulator Changed Colonic Transit Without Changing Fecal Output

An experimental cannabinoid-receptor modulator reduced morphine-induced slowing of colonic transit without changing fecal boli production in the reported experiment. Those outcomes are related, but they are not interchangeable measures of gastrointestinal benefit. The compound was not cannabis The supplied Iyer and colleagues preprint examined GAT358, a negative allosteric modulator of…

Spread the love

Read Article: A CB1 Modulator Changed Colonic Transit Without Changing Fecal Output

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us